OTCMKTS:PBSV Pharma-Bio Serv (PBSV) Stock Price, News & Analysis $0.46 +0.06 (+15.98%) As of 09/17/2026 11:09 AM Eastern Add Compare Share Share Stock Analysis Stock AnalysisChartDividendEarningsSEC Filings About Pharma-Bio Serv Stock (OTCMKTS:PBSV) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Pharma-Bio Serv alerts:Sign Up Key Stats Today's Range$0.46▼$0.4650-Day Range$0.40▼$0.5852-Week Range$0.37▼$1.36Volume600 shsAverage Volume1,992 shsMarket Capitalization$10.62 millionP/E Ratio46.44Dividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview Pharma-Bio Serv, Inc. operates as a compliance and technology transfer services consulting firm in Puerto Rico, the United States, Europe, Brazil, and internationally. The company provides technical compliance consulting services comprising regulatory compliance, validation, technology transfer, engineering, project management, and process support for the pharmaceutical, chemical manufacturing, biotechnology, medical device, cosmetic, food industries, and allied products companies. Pharma-Bio Serv, Inc. was founded in 1993 and is headquartered in Dorado, Puerto Rico. Read More Receive PBSV Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Pharma-Bio Serv and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. PBSV Stock News HeadlinesZacks Research Forecasts Lower Earnings for Pharma-Bio ServSeptember 18 at 1:13 AM | americanbankingnews.comPBSV Changes Proving to be Beneficial to BusinessSeptember 15 at 3:53 PM | msn.comAnalyst nicknamed “The Prophet” issues new warning for AmericaWhitney Tilson exposed a major company on 60 Minutes in an Emmy-winning investigation - the stock lost nearly 80% afterward. He also called the housing crisis and the collapse of Bear Stearns and Lehman Brothers before they happened. Now Tilson says the day after this year's midterm elections, America enters a period of economic change unlike anything seen in decades - and most investors are unprepared.September 18 at 1:00 AM | Stansberry Research (Ad)Pharma-Bio Serv (PBSV) Expected to Post Earnings on WednesdaySeptember 14, 2026 | americanbankingnews.comPBSV is a Small Stock Worth a LookJune 16, 2026 | finance.yahoo.comPharma-Bio Serv Inc.: Pharma-Bio Serv Announces Results for the Quarter Ended April 30, 2026June 15, 2026 | finanznachrichten.dePBSV Showing Improved Operations and Strong DividendMarch 18, 2026 | finance.yahoo.comPBSV Has Great Yield and Improved OperationsJanuary 30, 2026 | finance.yahoo.comSee More Headlines PBSV Stock Analysis - Frequently Asked Questions How have PBSV shares performed this year? Pharma-Bio Serv's stock was trading at $0.60 on January 1st, 2026. Since then, PBSV shares have decreased by 22.7% and is now trading at $0.4639. How were Pharma-Bio Serv's earnings last quarter? Pharma-Bio Serv Inc. (OTCMKTS:PBSV) issued its earnings results on Monday, June, 15th. The company reported $0.01 EPS for the quarter, missing analysts' consensus estimates of $0.03 by $0.02. The company earned $2.70 billion during the quarter, compared to analysts' expectations of $2.70 million. Pharma-Bio Serv had a trailing twelve-month return on equity of 2.34% and a net margin of 2.66%. How do I buy shares of Pharma-Bio Serv? Shares of PBSV stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Pharma-Bio Serv own? Based on aggregate information from My MarketBeat watchlists, some other companies that Pharma-Bio Serv investors own include AT&T (T), Annaly Capital Management (NLY), BlackRock Multi-Sector Income Trust (BIT), GE Aerospace (GE), ExxonMobil (XOM), Enterprise Products Partners (EPD) and First BanCorp. (FBP). Company Calendar Last Earnings6/15/2026Today9/17/2026Fiscal Year End10/31/2026Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorIndustrials Industry Consulting Sub-IndustryBusiness Services Current SymbolOTCMKTS:PBSV CIK1304161 Webwww.pharmabioserv.com Phone(787) 278-2709Fax787-796-5168Employees185Year Founded1993Profitability EPS (Trailing Twelve Months)$0.01 Trailing P/E Ratio46.44 Forward P/E Ratio11.60 P/E GrowthN/ANet Income-$100 thousand Net Margins2.66% Pretax Margin2.83% Return on Equity2.34% Return on Assets2.01% Debt Debt-to-Equity RatioN/A Current Ratio11.30 Quick Ratio10.80 Sales & Book Value Annual Sales$9 million Price / Sales1.18 Cash Flow$0.01 per share Price / Cash Flow71.66 Book Value$0.46 per share Price / Book1.01Miscellaneous Outstanding Shares22,900,000Free Float20,016,000Market Cap$10.62 million OptionableNot Optionable Beta0.71 Social Links 7 Stocks to Buy Before the Robotics RevolutionRobotics and automation are rapidly becoming essential infrastructure across healthcare, manufacturing, logistics, and many other industries. "Physical AI" is coming. Learn which seven companies are most positioned to benefit as intelligent robots enter the workforce.Get This Free Report This page (OTCMKTS:PBSV) was last updated on 9/18/2026 by MarketBeat.com Staff. From Our PartnersGold Miners Post Record Cash Flow Even as Prices Pull BackThe four largest gold miners are generating record free cash flow, even with gold pulling back from recent hig...Golden Portfolio | SponsoredIran War: Why Is Trump Protecting THEM?A powerful Middle Eastern government is reportedly seeking US intelligence, targeting help, and military prote...Banyan Hill Publishing | SponsoredThe retirement stock I'd buy before Nvidia todayIn 2014, Marc Chaikin pointed readers toward Nvidia. Now the 60-year Wall Street veteran and creator of the Ch...Chaikin Analytics | SponsoredMusk says UBI is coming. I say it's already here.Elon Musk says AI could make money irrelevant by 2036. One income program already exists today, funded not by ...Freedom Financial | SponsoredElon Musk’s Hushed FCC Filing. Sept 25th.Elon Musk quietly filed a document with the federal government tied to artificial intelligence, one of the lar...Paradigm Press | SponsoredA “bloodbath” Is ComingReports suggest some Silicon Valley billionaires are stockpiling gold, guns, and gas masks - or leaving the co...TradeSmith | SponsoredWhy major institutions are piling into this digital asset nowBlackRock, JPMorgan, Goldman Sachs, and Fidelity are reportedly accumulating a scarce blockchain asset - one t...Awesomely | SponsoredThe trade I’ve been waiting for since 2011Ross Givens, Director of Research at Traders Agency, is calling for gold to reach $10,000 an ounce this superc...Traders Agency | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Pharma-Bio Serv Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Pharma-Bio Serv With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
